IFN-β gene therapy induces systemic antitumor immunity against malignant glioma

Journal of Neuro-Oncology

Volumn 47, Issue 2, 2000, Pages 117-124

  Natsume, A ^a   Tsujimura, K ^b   Mizuno, M ^a   Takahashi, T ^b   Yoshida, J ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Antitumor immunity; Cationic liposome; CTL; Gene therapy; Glioma; IFN gene

Indexed keywords

BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; LIPOSOME; T LYMPHOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LINE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; FEMALE; GENE THERAPY; GLIOBLASTOMA; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTRACRANIAL TUMOR; MOUSE; NONHUMAN; SURVIVAL TIME; TUMOR CELL; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; BRAIN NEOPLASMS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE THERAPY; GLIOMA; HUMANS; INTERFERON-BETA; LIPOSOMES; MICE; PLASMIDS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0033848359     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006441030976     Document Type: Article

References (28)

1. Synergistic role of type I interferons in the induction of protective cytotoxic T lymphocytes
2. Block of a glioma cell line in S by interferon
3. Human brain tumor-derived cell lines: Growth rate reduced by human fibroblast interferon
4. Antitumor activity of interferon-β against malignant glioma in combination with chemotherapeutic agent of nitrosourea (ACNU)
5. Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression
6. Interferon production in glia and glioma cell lines
7. Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody
8. Growth inhibition of glioma cells of different cell lines by human interferon-β produced in the cells transfected with its gene by means of liposomes
9. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse
10. Studies of glioma in mice. 1. Experiments concerning glioma growth and hepatic mitotic activity
11. Selective rejection of H-2-deficient lymphoma variants suggest alternative immune defense strategy
12. Monoclonal antibodies specific to native murine T-cell receptor γδ: Analysis of γδ T cells during thymic ontogeny and in peripheral lymphoid organs
13. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of H-2(b) haplotype reveal genetic control of isotype expression
14. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: Evidence for I region gene duplication
15. Effect of in vivo administration of Lyt phenotype of T cells in lymphoid tissue and blocking of tumor rejection
16. Serological analysis of H-2 and Ia molecules with monoclonal antibodies
17. Secretion of human β-interferon into the cystic fluid of glioma transfected with the interferon gene
18. Antitumor effect of endogenous human β-interferon on malignant glioma and augmentation of the effect by tumor necrosis factor-α
19. Interleukin-2 gene therapy in a patient with glioblastoma
20. Treatment of 9L gliosarcoma with IL-4 producing 9L vaccine
21. Treatment of glioma by engineered interleukin-4-secreting cells
22. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ-retroviral gene transfer
23. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
24. Immune system in suicide-gene therapy
25. Thymidine kinase-mediated killing of rat brain tumors
26. Effect of human interferon β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells
27. 1: Into syngeneic mice
28. Interferon-β mediates stromal cell rescue of T cells from apoptosis